Is rapid liver fibrosis reversal possible?
According to the National Center for Biotechnology Information, there is increasing research data and clinical evidence showing that reversing fibrosis to a certain degree is now possible.
This is a new hope for many liver disease patients, as fibrosis was once considered an untreatable condition. But what should be done, and how long does it take for us to achieve it?
The key to fibrosis reversal: Anti-fibrotic properties
Based on research and scientific evidence, anti-fibrotic properties appear to be one of the most promising key factors in reversing fibrotic tissue in the liver1. Anti-fibrotic therapies focus on two areas2:
1. Reversal - Reduce fibrosis in seriously scarred livers.
2. Prevention - Control the generation of new scar tissue in the liver before fibrosis progresses to the advanced stage.
The ultimate goal is to reverse as much damaged liver cells back to its healthy, normal state, and also prevent normal tissue from becoming scarred.
Research on YHK Liver Therapy
Several clinical reports have demonstrated that YHK Therapy (a liver supplement from Japan), is an effective solution to revitalize fibrotic liver tissues and to protect against fibrotic injuries.
Research and studies published on PubMed.gov (U.S. National Library of Medicine) indicate that, YHK Therapy contains properties that are exceptionally effective at preventing inflammation and the reoccurrence of liver cell death, which is the cause of liver fibrosis.
- Fibrosis Regression - F2 to F0-1
In a study that was presented at the First JSH Single Topic Conference in Yamanashi, Japan3, subjects with liver fibrosis who were provided with YHK experienced a significant decrease in their activated stellate cells (damaged liver cells), suggesting YHK has a strong anti-fibrotic effect on the liver.
Another study that was presented by F. Marotta, MD, PhD at the Hiroshima University M.D. Lecture Presentation4 show that, 4 out of 6 liver fibrosis cases experienced regression in their liver fibrosis degree after taking YHK for 18 weeks. One of the patients even had an improvement from F2 to F0-1, demonstrating fibrosis is reversible with anti-fibrotic treatments.
- Fibrosis prevention
Several research studies published in world-renowned journals such as Digestive Diseases and Sciences5,6 and Liver International7 have demonstrated that YHK can remarkably lower inflammation level5,6 and significantly reduce oxidative stress7, indicating its strong effects in liver protection and fibrosis prevention.
Early management offers the best results
The research of YHK shows that even though preventing liver inflammation can be achieved quickly, reversing liver fibrosis is a different story. The time it takes would heavily depend on the individual’s liver condition and also their lifestyle habits. Generally speaking, early detection and management of liver fibrosis is the key to faster liver recovery.
While YHK is a liver supplement designed for liver support instead of a cure or treatment, its research has demonstrated that the anti-inflammation and anti-fibrotic properties can offer comprehensive protective effects for people with fibrotic liver injuries.
- National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339475/, (Accessed Date: 2019-04-16)
- National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846600/, (Accessed Date: 2019-04-16)
- Kyotsujigyo, https://www.kyotsujigyo.net/document/yhk/12.pdf, (Accessed Date: 2019-04-16)
- Kyotsujigyo, https://www.kyotsujigyo.net/document/yhk/17.pdf, (Accessed Date: 2019-04-16)
- National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pubmed/17394061, (Accessed Date: 2019-04-16)
- National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pubmed/16944007, (Accessed Date: 2019-04-16)
- National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pubmed/17311618, (Accessed Date: 2019-04-16)
- * All research and clinical data should be used as reference purposes only, results may vary.